Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.86 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.86 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.86 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.86 |
| ▸ | TTR | P02766 | 3/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.85 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.85 |
| ▸ | LMNA | P02545 | 1/20 | 0.85 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.85 |
| ▸ | NQO2 | P16083 | 4/20 | 0.78 |
| ▸ | ABL1 | P00519 | 3/20 | 0.78 |
| ▸ | BCR | P11274 | 3/20 | 0.78 |
| ▸ | ESR1 | P03372 | 2/20 | 0.78 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.78 |
| ▸ | AHR | P35869 | 2/20 | 0.78 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.78 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.78 |
| ▸ | TUBB | P07437 | 1/20 | 0.78 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29652111 | 1.00 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| SCHEMBL2516446 | 1.00 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| SCHEMBL29662231 | 1.00 | PTGS2 (0.86) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| SCHEMBL562335 | 0.92 | CYP1A1 (1.00) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| SCHEMBL30475363 | 0.92 | CYP1A1 (1.00) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| SCHEMBL562336 | 0.92 | CYP1A1 (1.00) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| Resveratrol 4'-Methyl Ether SCHEMBL4732963 | 0.92 | PTGS2 (1.00) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| Resveratrol 4'-Methyl Ether SCHEMBL563262 | 0.92 | PTGS2 (1.00) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| Resveratrol 4'-Methyl Ether SCHEMBL563261 | 0.92 | PTGS2 (1.00) | PTGS2CYP1A1CYP1B1ALOX5TTR | |
| SCHEMBL28899386 | 0.92 | PTGS2 (0.73) | PTGS2CYP1A1CYP1B1ALOX5TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117801459-A | High-toughness flame-retardant aging-resistant antistatic ABS material and preparation method thereof | 浙江东吴新材料股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-114709406-B | Sulfur-rich copolymer material, lithium sulfur battery positive electrode material, and preparation methods and applications thereof | 中国电建集团成都勘测设计研究院有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-114709406-A | Sulfur-rich copolymer material, lithium-sulfur battery positive electrode material, and preparation methods and applications thereof | 中国电建集团成都勘测设计研究院有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-117801459-A | High-toughness flame-retardant aging-resistant antistatic ABS material and preparation method thereof | 浙江东吴新材料股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20230309502-A1 | ANIMAL LITTER COMPOSITIONS AND METHOD OF AMMONIA ABATEMENT | CONTROLLED RELEASE TECHNOLOGIES, INC. (US) | 2023-10-05 | — | — | US | disclosed |
| WO-2023158815-A1 | ANIMAL LITTER COMPOSITIONS AND METHOD OF AMMONIA ABATMENT | CONTROLLED RELEASE TECHNOLOGIES, INC. (US) | 2023-08-24 | — | — | WO | disclosed |
| CN-114709406-B | Sulfur-rich copolymer material, lithium sulfur battery positive electrode material, and preparation methods and applications thereof | 中国电建集团成都勘测设计研究院有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114709406-A | Sulfur-rich copolymer material, lithium-sulfur battery positive electrode material, and preparation methods and applications thereof | 中国电建集团成都勘测设计研究院有限公司 | 2022-07-05 | — | — | CN | disclosed |
| US-9861564-B2 | Valeric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT, LLC (US) | 2018-01-09 | — | — | US | disclosed |
| US-9782335-B2 | Malic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-10-20 | — | — | US | disclosed |
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20070248693-A1 | Nutraceutical composition and method of use for treatment / prevention of cancer | MAZZIO ELIZABETH | 2007-10-25 | — | — | US | disclosed |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | NATIONAL INSTITUTES OF HEALTH | 2005-10-27 | — | — | US | disclosed |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | NATIONAL INSTITUTES OF HEALTH | 2005-10-27 | — | — | US | disclosed |
| WO-2003086414-A1 | STRUCTURAL MODIFICATION OF RESVERATROL: SODIUM RESVERASTATIN PHOSPHATE | ARIZONA BOARD OF REGENTS (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-2003086414-A1 | STRUCTURAL MODIFICATION OF RESVERATROL: SODIUM RESVERASTATIN PHOSPHATE | ARIZONA BOARD OF REGENTS (US) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | RB1, SIRT1, EP300 | PTGS2 3838/4885CYP1A1 1440/4885CYP1B1 902/4885 |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | SQLE, SMURF1, PIK3R1 | PTGS2 3228/4885CYP1A1 2625/4885CYP1B1 1478/4885 |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | PI4KB, HDAC4, PIK3CA | PTGS2 3996/4885CYP1A1 3525/4885CYP1B1 2430/4885 |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | CUTA, SUV39H1, RARA | PTGS2 2796/4885CYP1A1 348/4885CYP1B1 428/4885 |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | SMURF1, CUTA, SMURF2 | PTGS2 3901/4885CYP1A1 2419/4885CYP1B1 2175/4885 |
| US-20070248693-A1 | Nutraceutical composition and method of use for treatment / prevention of cancer | DLD, DERA, ALDOA | PTGS2 1380/4885CYP1A1 1403/4885CYP1B1 1227/4885 |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | SMARCC1, RARG, RARA | PTGS2 3031/4885CYP1A1 1950/4885CYP1B1 1679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.